Myopia Control 2020: Where are we and where are we heading?

Purpose This review arms practitioners with the evidence‐based information they need to fully manage myopia. Recent findings The recent peer‐reviewed literature is critically evaluated to provide a comprehensive analysis of the safety and efficacy of behavioural, optical and pharmaceutical myopia ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic & physiological optics Jg. 40; H. 3; S. 254 - 270
Hauptverfasser: Bullimore, Mark A, Richdale, Kathryn
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Wiley Subscription Services, Inc 01.05.2020
Schlagworte:
atropine
contact lenses
Myopia
myopia control
spectacles
myopia
spectacles
atropine
myopia control
contact lenses
ISSN:0275-5408, 1475-1313, 1475-1313
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose This review arms practitioners with the evidence‐based information they need to fully manage myopia. Recent findings The recent peer‐reviewed literature is critically evaluated to provide a comprehensive analysis of the safety and efficacy of behavioural, optical and pharmaceutical myopia management. Importantly, the paper addresses not only who to treat, but how to treat them, and when to stop or modify treatments. Finally, the paper discusses expectations for treatment and why slowing myopia by even 1 dioptre improves long term health outcomes. Summary The management of an individual child should be underpinned by the evidence‐based literature and clinicians must stay alert to ongoing myopia research that will undoubtedly result in an evolution of the standard of care for the myopic and pre‐myopic child.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0275-5408
1475-1313
1475-1313
DOI:10.1111/opo.12686